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ABSTRACT 
Glucocorticoid-induced osteoporosis is the most common cause of secondary osteoporosis. 
Expression of bone-related genes may correspond to alteration in bone metabolism with 
glucocorticoid exposure. Piper sarmentosum (Ps) extract is known to possess antioxidant and 
anti-inflammatory activities. In this study, we determined the correlation between the effects 
of Ps leaf extract with mRNA expression of osteoblast and osteoclast related genes in 
glucocorticoidinduced osteoporotic rats. Sprague-Dawley rats were adrenalectomized and 
divided into four groups: G1: sham-operated control; G2: adrenalectomized (adrx) control; 
G3: adrx and given Ps 125 mg/kg/day; and G4: adrx and given GCA 120 mg/kg/day. These 
rats were given dexamethasone replacement 120μg/kg body weight/day intramuscularly. 
Treatment with water-based Ps leaf extract 125mg/kg/day and GCA 120 mg/kg/day were 
given for 2 months. The left femur was dissected out for gene expression analysis. The results 
showed that Ps leaf extract had increased the osteoprotegerin mRNA expression (p<0.05), 
whereas GCA increased the osteoprotegerin and osteocalcin mRNA expression (p<0.05). 
This suggests that Ps leaf extract was able to prevent bone loss due to long-term 
glucocorticoid therapy by increasing the expression of bone formation related genes. Thus Ps 
may have the potential to be used as prophylaxis against osteoporosis and osteoporotic 
fracture in patients on long-term glucocorticoid treatment. 
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